Tag: #Global Trends

Pharmaceutical flagships GSK and Ionis Pharmaceuticals have formally published positive primary data from two pivotal Phase III trials evaluating bepirovirsen,... Read more

The United States Food and Drug Administration (FDA) has granted formal regulatory approval to AstraZeneca’s PD-L1 inhibitor, Imfinzi (durvalumab), for... Read more

French biopharmaceutical flagship Sanofi announced that the U.S. Food and Drug Administration (FDA) has formally accepted the New Drug Application... Read more

Medical technology conglomerate Abbott announced on Wednesday that it has secured Europe’s CE mark for its novel Libre Duo device,... Read more

The United States Food and Drug Administration (FDA) has granted formal regulatory approval to AbbVie’s novel therapeutic agent engineered for... Read more

U.S. clinical-stage biotech Viridian Therapeutics is shoring up its commercial supply infrastructure as its thyroid eye disease (TED) candidate, veligrotug,... Read more

Healthcare conglomerate Johnson & Johnson (J&J) is dismissing 56 employees at its global corporate headquarters in New Brunswick, New Jersey.... Read more

The United States Food and Drug Administration (FDA) has granted formal accelerated approval to Gilead Sciences’ proprietary therapeutic asset, Hepcludex... Read more

Multinational pharmaceutical flagship AstraZeneca announced on Wednesday that the U.S. Food and Drug Administration (FDA) has formally extended its regulatory... Read more